About
Technology
Issues
FAQ
Links
Official Page
Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.